It can be claimed that the ALO activates PKC and Akt phosphorylation and promotes GLUT4 expression, thus facilitating glucose utilization to ameliorate insulin resistance in T2DM. The gene discussed is PRRT2; the disease is type 2 diabetes mellitus.